α-Synuclein pathology in post-mortem retina and optic nerve is specific for α-synucleinopathies

α-Synuclein pathology in post-mortem retina and optic nerve is specific for α-synucleinopathies

Abstract There is increasing interest in studying retinal biomarkers for various neurodegenerative diseases. Specific protein aggregates associated with neurodegenerative diseases are present in the retina and could be visualised in a non-invasive way. This study aims to assess the specificity and s...

Full description

Bibliographic Details
Main Authors:	Frederique J. Hart de Ruyter, Tjado H. J. Morrema, Jurre den Haan, Gina Gase, Jos W. R. Twisk, Johannes F. de Boer, Philip Scheltens, Femke H. Bouwman, Frank D. Verbraak, Annemieke J. M. Rozemuller, Jeroen J. M. Hoozemans
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-08-01
Series:	npj Parkinson's Disease
Online Access:	https://doi.org/10.1038/s41531-023-00570-5

Similar Items

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
by: Jurre den Haan, et al.
Published: (2018-12-01)

Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer’s disease brains: Implications for in-vivo diagnostics
by: Jurre den Haan, et al.
Published: (2018-08-01)

Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
by: Chao Peng, et al.
Published: (2018-01-01)

α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
by: Matthias Schmitz, et al.
Published: (2023-03-01)

α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies
by: Hazem Abdelkarim, et al.
Published: (2018-08-01)

α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
by: Alessandra Bigi, et al.
Published: (2023-01-01)

Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
by: P.G. Foulds, et al.
Published: (2012-01-01)

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.
by: Gaia Codolo, et al.
Published: (2013-01-01)

Investigating brain-derived α-synuclein fibrils and diagnostic biomarkers of synucleinopathies
by: Lee, S
Published: (2023)

Solubility of α-synuclein species in the L62 mouse model of synucleinopathy
by: Karima Schwab, et al.
Published: (2024-03-01)

α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?
by: Simon Oliver Hoppe, et al.
Published: (2021-06-01)

Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?
by: Arati Tripathi, et al.
Published: (2021-12-01)

Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
by: Nahuai Badiola, et al.
Published: (2011-01-01)

Lovastatin Alleviates α-Synuclein Aggregation and Phosphorylation in Cellular Models of Synucleinopathy
by: Lijun Dai, et al.
Published: (2021-07-01)

Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
by: Grace Kuo, et al.
Published: (2025-01-01)

Gut Microbiome-Modified Polyphenolic Compounds Inhibit α-Synuclein Seeding and Spreading in α-Synucleinopathies
by: Tritia R. Yamasaki, et al.
Published: (2020-05-01)

Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity
by: Zachary A. Sorrentino, et al.
Published: (2017-05-01)

Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies.
by: Haya Kisos, et al.
Published: (2012-01-01)

Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy
by: Xue-Jing Wang, et al.
Published: (2020-02-01)

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
by: Hao Gu, et al.
Published: (2021-03-01)

α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies
by: Hideya Mizuno, et al.
Published: (2011-01-01)

Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies
by: Juan Huang, et al.
Published: (2024-03-01)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
by: Akio Sekigawa, et al.
Published: (2015-05-01)

In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
by: Maria Fouka, et al.
Published: (2020-09-01)

LRP10 in α-synucleinopathies
by: Guerreiro, R, et al.
Published: (2018)

Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies
by: R.T. Bartus, et al.
Published: (2015-06-01)

Selective vulnerability in α-synucleinopathies.
by: Alegre-Abarrategui, J, et al.
Published: (2019)

α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation
by: Yaoyun Kuang, et al.
Published: (2024-11-01)

A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies.
by: Jess-Karan S Dhillon, et al.
Published: (2017-01-01)

Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy
by: An Cheng, et al.
Published: (2021-05-01)

Lysosomal exocytosis releases pathogenic α-synuclein species from neurons in synucleinopathy models
by: Ying Xue Xie, et al.
Published: (2022-08-01)

Combining skin and olfactory α-synuclein seed amplification assays (SAA)—towards biomarker-driven phenotyping in synucleinopathies
by: A. Kuzkina, et al.
Published: (2023-05-01)

Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
by: Jacqui T. Nimmo, et al.
Published: (2023-01-01)

Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
by: Martin Kallab, et al.
Published: (2018-07-01)

Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathies
by: Ethan W. Hass, et al.
Published: (2021-08-01)

Autonomic Dysfunction in α-Synucleinopathies
by: José Javier Mendoza-Velásquez, et al.
Published: (2019-04-01)

Bradykinesia and postural instability in a model of prodromal synucleinopathy with α-synuclein aggregation initiated in the gigantocellular nuclei
by: Vasileios Theologidis, et al.
Published: (2025-02-01)

Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils
by: Joseph R. Patterson, et al.
Published: (2019-10-01)

Poly (ADP-ribose) Interacts With Phosphorylated α-Synuclein in Post Mortem PD Samples
by: Laura N. Puentes, et al.
Published: (2021-06-01)

Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy
by: Omar El-Agnaf, et al.
Published: (2017-08-01)